{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:20:08Z","timestamp":1760404808998},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"S24","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Emerging evidence suggests retroviruses play a role in the pathophysiology of amyotrophic lateral sclerosis (ALS). Specifically, activation of ancient viral genes embedded in the human genome is theorized to lead to motor neuron degeneration. We explore whether connections exist between ALS and retroviruses through protein interaction networks (PIN) and pathway analysis, and consider the potential roles in drug target discovery. Protein database and pathway\/network analytical software including Ingenuity Pathway BioProfiler, STRING, and CytoScape were utilized to identify overlapping protein interaction networks and extract core cluster (s) of retroviruses and ALS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Topological and statistical analysis of the ALS-PIN and retrovirus-PIN identified a shared, essential protein network and a core cluster with significant connections with both networks. The identified core cluster has three interleukin molecules IL10, Il-6 and IL-1B, a central apoptosis regulator TP53, and several major transcription regulators including MAPK1, ANXA5, SQSTM1, SREBF2, and FADD. Pathway enrichment analysis showed that this core cluster is associated with the glucocorticoid receptor singling and neuroinflammation signaling pathways. For confirmation purposes, we applied the same methodology to the West Nile and Polio virus, which demonstrated trivial connectivity with ALS, supporting the unique connection between ALS and retroviruses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Bioinformatics analysis provides evidence to support pathological links between ALS and retroviral activation. The neuroinflammation and apoptotic regulation pathways are specifically implicated. The continuation and further analysis of large scale genome studies may prove useful in exploring genes important in retroviral activation and ALS, which may help discover new drug targets.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12859-019-3249-8","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T08:05:23Z","timestamp":1576829123000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between ALS and retroviruses: evidence from bioinformatics analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Jon P.","family":"Klein","sequence":"first","affiliation":[]},{"given":"Zhifu","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Nathan P.","family":"Staff","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"issue":"2","key":"3249_CR1","first-page":"252","volume":"30","author":"AE Volk","year":"2018","unstructured":"Volk AE, Weishaupt JH, Andersen PM, Ludolph AC, Kubisch C. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Med Genet. 2018;30(2):252\u20138.","journal-title":"Med Genet"},{"issue":"1","key":"3249_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton AE, Chio A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17(1):17\u201323.","journal-title":"Nat Neurosci"},{"issue":"16","key":"3249_CR3","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1056\/NEJMc1710379","volume":"377","author":"RH Brown Jr","year":"2017","unstructured":"Brown RH Jr, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(16):1602.","journal-title":"N Engl J Med"},{"issue":"9","key":"3249_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ng.3622","volume":"48","author":"W van Rheenen","year":"2016","unstructured":"van Rheenen W, Shatunov A, Dekker AM, McLaughlin RL, Diekstra FP, Pulit SL, van der Spek RA, Vosa U, de Jong S, Robinson MR, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1043\u20138.","journal-title":"Nat Genet"},{"issue":"6","key":"3249_CR5","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34(6):404\u201323.","journal-title":"Trends Genet"},{"issue":"1\u20132","key":"3249_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2005.09.005","volume":"240","author":"A Verma","year":"2006","unstructured":"Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci. 2006;240(1\u20132):59\u201364.","journal-title":"J Neurol Sci"},{"issue":"3","key":"3249_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1055\/s-0031-1287653","volume":"31","author":"J Lyons","year":"2011","unstructured":"Lyons J, Venna N, Cho TA. Atypical nervous system manifestations of HIV. Semin Neurol. 2011;31(3):254\u201365.","journal-title":"Semin Neurol"},{"issue":"12","key":"3249_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11908-017-0606-5","volume":"19","author":"S Farhadian","year":"2017","unstructured":"Farhadian S, Patel P, Spudich S. Neurological complications of HIV infection. Curr Infect Dis Rep. 2017;19(12):50.","journal-title":"Curr Infect Dis Rep"},{"issue":"2","key":"3249_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.antiviral.2013.05.006","volume":"99","author":"T Alfahad","year":"2013","unstructured":"Alfahad T, Nath A. Retroviruses and amyotrophic lateral sclerosis. Antivir Res. 2013;99(2):180\u20137.","journal-title":"Antivir Res"},{"issue":"6","key":"3249_CR10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1212\/WNL.57.6.995","volume":"57","author":"A Moulignier","year":"2001","unstructured":"Moulignier A, Moulonguet A, Pialoux G, Rozenbaum W. Reversible ALS-like disorder in HIV infection. Neurology. 2001;57(6):995\u20131001.","journal-title":"Neurology"},{"issue":"6","key":"3249_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.57.6.1094","volume":"57","author":"DJ MacGowan","year":"2001","unstructured":"MacGowan DJ, Scelsa SN, Waldron M. An ALS-like syndrome with new HIV infection and complete response to antiretroviral therapy. Neurology. 2001;57(6):1094\u20137.","journal-title":"Neurology"},{"issue":"17","key":"3249_CR12","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1212\/WNL.0000000000003258","volume":"87","author":"LN Bowen","year":"2016","unstructured":"Bowen LN, Tyagi R, Li W, Alfahad T, Smith B, Wright M, Singer EJ, Nath A. HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy. Neurology. 2016;87(17):1756\u201362.","journal-title":"Neurology"},{"issue":"4","key":"3249_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/01.wnl.0000297552.13219.b4","volume":"70","author":"AL McCormick","year":"2008","unstructured":"McCormick AL, Brown RH Jr, Cudkowicz ME, Al-Chalabi A, Garson JA. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 2008;70(4):278\u201383.","journal-title":"Neurology"},{"issue":"3","key":"3249_CR14","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1212\/01.WNL.0000150899.76130.71","volume":"64","author":"AJ Steele","year":"2005","unstructured":"Steele AJ, Al-Chalabi A, Ferrante K, Cudkowicz ME, Brown RH Jr, Garson JA. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology. 2005;64(3):454\u20138.","journal-title":"Neurology"},{"issue":"1","key":"3249_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/ana.22149","volume":"69","author":"R Douville","year":"2011","unstructured":"Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol. 2011;69(1):141\u201351.","journal-title":"Ann Neurol"},{"issue":"307","key":"3249_CR16","doi-asserted-by":"publisher","first-page":"307ra153","DOI":"10.1126\/scitranslmed.aac8201","volume":"7","author":"W Li","year":"2015","unstructured":"Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, et al. Human endogenous retrovirus-K contributes to motor neuron disease. Sci Transl Med. 2015;7(307):307ra153.","journal-title":"Sci Transl Med"},{"key":"3249_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/1471-2164-9-354","volume":"9","author":"A Flockerzi","year":"2008","unstructured":"Flockerzi A, Ruggieri A, Frank O, Sauter M, Maldener E, Kopper B, Wullich B, Seifarth W, Muller-Lantzsch N, Leib-Mosch C, et al. Expression patterns of transcribed human endogenous retrovirus HERV-K (HML-2) loci in human tissues and the need for a HERV Transcriptome project. BMC Genomics. 2008;9:354.","journal-title":"BMC Genomics"},{"issue":"6","key":"3249_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1186\/gb-2001-2-6-reviews1017","volume":"2","author":"DJ Griffiths","year":"2001","unstructured":"Griffiths DJ. Endogenous retroviruses in the human genome sequence. Genome Biol. 2001;2(6):1017 REVIEWS.","journal-title":"Genome Biol"},{"issue":"11","key":"3249_CR19","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1128\/JVI.00669-14","volume":"88","author":"D Brinzevich","year":"2014","unstructured":"Brinzevich D, Young GR, Sebra R, Ayllon J, Maio SM, Deikus G, Chen BK, Fernandez-Sesma A, Simon V, Mulder LC. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes. J Virol. 2014;88(11):6213\u201323.","journal-title":"J Virol"},{"issue":"17\u201318","key":"3249_CR20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.drudis.2007.07.011","volume":"12","author":"H Ruffner","year":"2007","unstructured":"Ruffner H, Bauer A, Bouwmeester T. Human protein-protein interaction networks and the value for drug discovery. Drug Discov Today. 2007;12(17\u201318):709\u201316.","journal-title":"Drug Discov Today"},{"issue":"Database issue","key":"3249_CR21","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"3249_CR22","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"key":"3249_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4:2.","journal-title":"BMC Bioinform"},{"issue":"8","key":"3249_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, Fridman WH, Pages F, Trajanoski Z, Galon J. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091\u20133.","journal-title":"Bioinformatics"},{"issue":"1","key":"3249_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","volume":"31","author":"SH Appel","year":"2010","unstructured":"Appel SH, Beers DR, Henkel JS. T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol. 2010;31(1):7\u201317.","journal-title":"Trends Immunol"},{"issue":"3","key":"3249_CR26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/glia.20928","volume":"58","author":"S Lehnardt","year":"2010","unstructured":"Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in toll-like receptor-mediated neuronal injury. Glia. 2010;58(3):253\u201363.","journal-title":"Glia"},{"issue":"1","key":"3249_CR27","first-page":"4","volume":"30","author":"SH Appel","year":"2011","unstructured":"Appel SH, Zhao W, Beers DR, Henkel JS. The microglial-motoneuron dialogue in ALS. Acta Myol. 2011;30(1):4\u20138.","journal-title":"Acta Myol"},{"issue":"1","key":"3249_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/archneur.1993.00540010026013","volume":"50","author":"JI Engelhardt","year":"1993","unstructured":"Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol. 1993;50(1):30\u20136.","journal-title":"Arch Neurol"},{"issue":"4","key":"3249_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","volume":"26","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26(4):459\u201370.","journal-title":"Muscle Nerve"},{"issue":"7","key":"3249_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377.","journal-title":"Nat Rev Immunol"},{"key":"3249_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1750-1326-9-56","volume":"9","author":"S Rossi","year":"2014","unstructured":"Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, et al. Interleukin-1beta causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol Neurodegener. 2014;9:56.","journal-title":"Mol Neurodegener"},{"key":"3249_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1742-2094-10-59","volume":"10","author":"C Song","year":"2013","unstructured":"Song C, Zhang Y, Dong Y. Acute and subacute IL-1beta administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration. J Neuroinflammation. 2013;10:59.","journal-title":"J Neuroinflammation"},{"issue":"29","key":"3249_CR33","first-page":"2259","volume":"7","author":"F Fregnan","year":"2012","unstructured":"Fregnan F, Muratori L, Simoes AR, Giacobini-Robecchi MG, Raimondo S. Role of inflammatory cytokines in peripheral nerve injury. Neural Regen Res. 2012;7(29):2259\u201366.","journal-title":"Neural Regen Res"},{"issue":"3","key":"3249_CR34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1523\/JNEUROSCI.0854-15.2016","volume":"36","author":"M Gravel","year":"2016","unstructured":"Gravel M, Beland LC, Soucy G, Abdelhamid E, Rahimian R, Gravel C, Kriz J. IL-10 controls early microglial phenotypes and disease onset in ALS caused by Misfolded superoxide dismutase 1. J Neurosci. 2016;36(3):1031\u201348.","journal-title":"J Neurosci"},{"issue":"2","key":"3249_CR35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s13311-015-0338-x","volume":"12","author":"EL Scotter","year":"2015","unstructured":"Scotter EL, Chen HJ, Shaw CE. TDP-43 Proteinopathy and ALS: insights into disease mechanisms and therapeutic targets. Neurotherapeutics. 2015;12(2):352\u201363.","journal-title":"Neurotherapeutics"},{"key":"3249_CR36","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1038\/ncomms6791","volume":"6","author":"S Lee","year":"2015","unstructured":"Lee S, Lee TA, Lee E, Kang S, Park A, Kim SW, Park HJ, Yoon JH, Ha SJ, Park T, et al. Identification of a subnuclear body involved in sequence-specific cytokine RNA processing. Nat Commun. 2015;6:5791.","journal-title":"Nat Commun"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-3249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-3249-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-3249-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T23:37:02Z","timestamp":1722209822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-3249-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":36,"journal-issue":{"issue":"S24","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3249"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-3249-8","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"20 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"680"}}